Vitamin D Receptor Overexpression in β-Cells Ameliorates Diabetes in Mice.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 32086292.
- Also identified by DOI 10.2337/db19-0757 and PMC identifier 7171966.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Vitamin D deficiency has been associated with increased incidence of diabetes, both in humans and in animal models. In addition, an association between vitamin D receptor (VDR) gene polymorphisms and diabetes has also been described. However, the involvement of VDR in the development of diabetes, specifically in pancreatic β-cells, has not been elucidated yet. Here, we aimed to study the role of VDR in β-cells in the pathophysiology of diabetes. Our results indicate that <i>Vdr</i> expression was modulated by glucose in healthy islets and decreased in islets from both type 1 diabetes and type 2 diabetes mouse models. In addition, transgenic mice overexpressing VDR in β-cells were protected against streptozotocin-induced diabetes and presented a preserved β-cell mass and a reduction in islet inflammation. Altogether, these results suggest that sustained VDR levels in β-cells may preserve β-cell mass and β-cell function and protect against diabetes.
Medical subject headings
- Insulin-Like Growth Factor II
- Insulin-Secreting Cells
- Receptors, Calcitriol